Zoetis - 5 Year Stock Split History | ZTS

Stock split history for Zoetis since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Zoetis Annual Stock Splits
Zoetis Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.773B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.806B 11.74
Grifols (GRFS) Spain $14.462B 17.65
Tilray (TLRY) United States $10.152B 0.00
Neurocrine Biosciences (NBIX) United States $9.559B 2108.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.781B 12.60
Ionis Pharmaceuticals (IONS) United States $7.085B 0.00
Sage Therapeutics (SAGE) United States $6.139B 0.00
Impax Laboratories (AMRX) United States $5.895B 0.00
Nektar Therapeutics (NKTR) United States $5.888B 8.44
Catalent (CTLT) United States $5.453B 22.87
Loxo Oncology (LOXO) United States $5.106B 0.00
United Therapeutics (UTHR) United States $4.986B 8.15
Taro Pharmaceutical Industries (TARO) Israel $4.078B 15.10
FibroGen (FGEN) United States $3.574B 0.00
Endo (ENDP) Ireland $3.026B 4.64
USANA Health Sciences (USNA) United States $2.867B 24.40
Madrigal Pharmaceuticals (MDGL) United States $2.840B 0.00
Heron Therapeutics (HRTX) United States $2.212B 0.00
Aerie Pharmaceuticals (AERI) United States $2.171B 0.00
Xencor (XNCR) United States $2.130B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.036B 275.11
Endocyte (ECYT) United States $1.934B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 0.00
PTC Therapeutics (PTCT) United States $1.703B 0.00
Corcept Therapeutics (CORT) United States $1.502B 22.05
Enanta Pharmaceuticals (ENTA) United States $1.473B 18.01
Esperion Therapeutics (ESPR) United States $1.461B 0.00
Zogenix (ZGNX) United States $1.460B 0.00
Portola Pharmaceuticals (PTLA) United States $1.458B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.439B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
TESARO (TSRO) United States $1.382B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.275B 0.00
Tricida (TCDA) United States $1.251B 0.00
TherapeuticsMD (TXMD) United States $1.173B 0.00
ImmunoGen (IMGN) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.844B 0.00
Radius Health (RDUS) United States $0.715B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.645B 0.00
Flexion Therapeutics (FLXN) United States $0.642B 0.00
GlycoMimetics (GLYC) United States $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
ChemoCentryx (CCXI) United States $0.508B 40.20
Xeris Pharmaceuticals (XERS) United States $0.484B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Dova Pharmaceuticals (DOVA) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
Odonate Therapeutics (ODT) United States $0.466B 0.00
OptiNose (OPTN) United States $0.448B 0.00
Dermira (DERM) United States $0.445B 0.00
ArQule (ARQL) United States $0.435B 0.00
Aquestive Therapeutics (AQST) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.88
Zafgen (ZFGN) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.397B 0.00
Mast Therapeutics (SVRA) United States $0.382B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.378B 0.00
Concert Pharmaceuticals (CNCE) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.371B 0.00
Depomed (ASRT) United States $0.347B 12.93
Aclaris Therapeutics (ACRS) United States $0.329B 0.00
Tapimmune (MRKR) United States $0.325B 0.00
Aratana Therapeutics (PETX) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.323B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
CASI Pharmaceuticals (CASI) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.296B 0.00
Translate Bio (TBIO) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.288B 0.00
ElectroCore (ECOR) United States $0.267B 0.00
IMV INC (IMV) Canada $0.256B 0.00
Affimed (AFMD) Germany $0.253B 0.00
Opexa Therapeutics (ACER) United States $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.240B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.221B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
Tyme Technologies (TYME) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
Neon Therapeutics (NTGN) United States $0.202B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.189B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
ContraFect (CFRX) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
Recro Pharma (REPH) United States $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.157B 0.00
Melinta Therapeutics (MLNT) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
MediWound (MDWD) Israel $0.153B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
DURECT (DRRX) United States $0.147B 0.00
Adherex Technologies (FENC) United States $0.145B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.132B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.131B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.115B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
Achaogen (AKAO) United States $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.099B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
BioLineRx (BLRX) Israel $0.074B 0.00
Forward Pharma (FWP) Denmark $0.072B 0.00
Natural Alternatives (NAII) United States $0.072B 8.01
Immune Design (IMDZ) United States $0.071B 0.00
Novan (NOVN) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Trillium Therapeutics (TRIL) Canada $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
KemPharm (KMPH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.037B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 7.50
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Shineco (TYHT) China $0.017B 1.72
Aradigm (ARDM) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00